All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Moderna will offer free COVID-19 shots to uninsured after PHE ends
Feb 16, 2023
Moderna faces pressure since the US government subsidized its vaccine development.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
First needle-free COVID-19 vaccines receive approval in India, China
Sep 07, 2022
Nasal and inhaled vaccines place doses directly where the virus enters the body, such as in the nose or mouth.
COVID-19 vaccination does not negatively impact fertility
Aug 24, 2022
The findings were seen for women undergoing in vitro fertilization-fresh embryo transfer cycle.
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.